Table 3.

Procedural Complications by Antithrombotic and Bleeding Avoidance Strategy

	Heparin	Bivalirudin	Heparin + VCD	Bivalirudin + VCD
Access Site Complication, %	4.41	3.23*	2.54*	1.47**
Distal embolization, %	1.87	1.17	1.85	2.83***
Access site occlusion, %	1.22	0.51*	0.99	0.73

VCD indicates vascular closure device.

^*Lower rate than in heparin group (p<0.05).

^**Lower rate of access site complication than all other groups (p<0.05).

^***Higher rate than in heparin group (p<0.05).